Evaluation of Botulinum TOXin Type A in the Treatment of Buerger's Disease

Conditions:   Buerger Disease;   Raynaud Syndrome Intervention:   Drug: BOTOX INJECTION Sponsor:   University Hospital, Toulouse Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials